Filing Details

Accession Number:
0001209191-22-003402
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-14 20:42:49
Reporting Period:
2022-01-13
Accepted Time:
2022-01-14 20:42:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1601830 Recursion Pharmaceuticals Inc. RXRX Biological Products, (No Disgnostic Substances) (2836) 464099738
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856369 Christopher Gibson C/o Recursion Pharmaceuticals
41 S. Rio Grande Street
Salt Lake City UT 84101
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2022-01-13 87,000 $0.00 110,470 No 4 C Direct
Class A Common Stock Disposition 2022-01-13 78,206 $14.26 32,264 No 4 S Direct
Class A Common Stock Disposition 2022-01-13 8,794 $14.96 23,470 No 4 S Direct
Class A Common Stock Acquisiton 2022-01-14 254,000 $0.00 277,470 No 4 C Direct
Class A Common Stock Disposition 2022-01-14 254,000 $13.57 23,470 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 S Direct
No 4 S Direct
No 4 C Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Class B Common Stock Disposition 2021-12-28 75,000 $0.00 75,000 $0.00
Class A Common Stock Class B Common Stock Disposition 2022-01-13 87,000 $0.00 87,000 $0.00
Class A Common Stock Class B Common Stock Disposition 2022-01-14 254,000 $0.00 254,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,119,342 No 5 G Direct
8,032,342 No 4 C Direct
7,778,342 No 4 C Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Class A Common Stock Stock Option (Right to Buy) $2.47 2030-12-30 1,471,354 1,471,354 Direct
Class A Common Stock Class B Common Stock $0.00 550,000 550,000 Indirect
Class A Common Stock Class B Common Stock $0.00 550,000 550,000 Indirect
Class A Common Stock Class B Common Stock $0.00 146,875 146,875 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2030-12-30 1,471,354 1,471,354 Direct
550,000 550,000 Indirect
550,000 550,000 Indirect
146,875 146,875 Indirect
Footnotes
  1. Represents the conversion of Class B Common Stock into Class A Common Stock.
  2. Shares were sold by a lender to the Reporting Person to satisfy a margin call related to a loan in which the shares served as collateral.
  3. This transaction was executed in multiple trades at prices ranging from $13.80 to $14.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  4. This transaction was executed in multiple trades at prices ranging from $14.80 to $15.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  5. This transaction was executed in multiple trades at prices ranging from $13.09 to $14.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  6. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
  7. The option, originally for 1,500,000 shares, of which 28,646 shares have been exercised, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
  8. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
  9. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
  10. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.